TCT-802 Impact of diabetes mellitus on 1-year outcomes of Absorb Bioresorbable vascular scaffold vs. Everolimus-eluting Metallic stent: a propensity matched Analysis of COMPARE II, RAI and MAASSTAD-ABSORB Prospective Registries

Authors :: Paola Tellaroli
Pieter C. Smits
Georgios J. Vlachojannis
Alfonso Ielasi
Valeria Paradies
Bernardo Cortese
Bruno Loi
Giuseppe Steffenino
Daisuke Ueshima
Giulia Masiero
Marco Mojoli
Attilio Varricchio
Giuseppe Tarantini
Gaetano Di Palma
Source :: Journal of the American College of Cardiology. 70:B326
Publication Year :: 2017
Publisher :: Elsevier BV, 2017.
Abstract: Diabetes mellitus (DM) is associated with increased risk of subsequent events after PCI. To evaluate the impact of Absorb bioresorbable vascular scaffold (BVS) in this setting, we aimed to compare the 1-year outcomes of Absorb BVS versus 2nd generation drug eluting stents (DES) by pooling diabetic

Subjects :: medicine.medical_specialty
Everolimus
business.industry
medicine.medical_treatment
Urology
Stent
medicine.disease
Surgery
Increased risk
Diabetes mellitus
Propensity score matching
Conventional PCI
medicine
Cardiology and Cardiovascular Medicine
business
medicine.drug
Bioresorbable vascular scaffold

Full Text Access

Tools